VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2020 | Acalabrutinib monotherapy in mature B-cell malignancies

Richard Furman, MD, of the Weill Cornell Medical College, New York, NY, discusses the safety of acalabrutinib monotherapy in mature B-cell malignancies and goes on to discuss the long-term follow-up of efficacy data. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter